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Abstract
Background: Standards in treatment of acute cholecystitis (AC) in the elderly and high-risk patients has not been
established. Our study evaluated the efficacy and safety of B-mode ultrasound-guided percutaneous transhepatic
gallbladder drainage (PTGD) in combination with laparoscopic cholecystectomy (LC) for acute cholecystitis (AC) in
elderly and high-risk patients.
Methods: Our study enrolled 35 elderly and high-risk AC patients, hospitalized between January 2010 and April 2014 at
the Wenzhou People's Hospital. The patients underwent B-mode ultrasound-guided PTGD and LC (PTGD + LC group).
As controls, a separate group of 35 elderly and high-risk AC patients who underwent LC alone (LC group) during the
same period at the same hospital were randomly selected from a pool of 186 such cases. The volume of bleeding,
surgery time, postoperative length of stay, conversion rate to laparotomy and complication rates (bile leakage, bleeding,
incisional hernia, incision infection, pulmonary infarction and respiratory failure) were recorded for each patient in the
two groups.
Results: All patients in the PTGD + LC group successfully underwent PTGD. In the PTGD + LC group, abdominal pain in
patients was relieved and leukocyte count, alkaline phosphatase level, total bilirubin and carbohydrate antigen 19-9
(CA19-9) decreased to normal range, and alanine aminotransferase and aspartate aminotransferase levels improved
significantly within 72 h after treatment. All patients in the PTGD + LC group underwent LC within 6–10 weeks after PTGD.
Our study revealed that PTGD + LC showed a significantly higher efficacy and safety compared to LC alone in AC
treatment, as measured by the following parameters: duration of operation, postoperative length of hospital stay,
volume of bleeding, conversion rate to laparotomy and complication rate (operation time of LC: 55.6 ± 23.3 min
vs. 91.35 ± 25.1 min; hospitalized period after LC: 3.0 ± 1.3 d vs. 7.0 ± 1.7 d; intraoperative bleeding: 28.7 ± 15.2 ml vs. 60.38
± 16.4 ml; conversion to laparotomy: 3 cases vs. 10 cases; complication: 3 cases vs. 8 cases; all P < 0.05 ).
Conclusion: Our results suggest that B-mode ultrasound-guided PTGD in combination with LC is superior to LC alone for
treatment of AC in elderly and high-risk patients, showing multiple advantages of minimal wounding, accelerated
recovery, higher safety and efficacy, and fewer complications.
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Background
Acute cholecystitis (AC) is an inflammatory gallbladder
disease caused by the obstruction and bacterial invasion
of the cystic duct, and more than 90 % of AC cases are
associated with cholelithiasis or gallstones [1]. The inci-
dence of AC increases with age and shows dramatic gen-
der differences, at 11.5 % in men and 22.4 % in women
by age 60, and AC is the most common cause of acute
abdominal surgeries in the elderly [2, 3]. Elderly AC pa-
tients have higher postoperative mortality and morbidity
rates, increased complication rates, longer length of hos-
pital stays and longer recovery times [4]. In most AC pa-
tients, laparoscopic cholecystectomy (LC) can rapidly
relieve the signs and symptoms of inflammation within
48–72 h [5, 6]. Nevertheless, in elderly AC patients with
other life-threatening comorbidities, considered as the
high-risk AC group, LC can lead to high morbidity of up
to 41 % and mortality of up to 4.5 % during the acute
phase [7, 8]. In case of severe or complex cholecystitis in
elderly AC patients, LC treatment is associated with
higher rates of conversion to open cholecystectomy, with
increased postoperative complications and longer lengths
of hospital stay [9, 10]. For example, in elderly and high-
risk AC patients, the perioperative mortality rate is high
at 19 % for emergency cholecystectomy. Further, in sev-
eral instances in elderly and high-risk patients, it is dif-
ficult to complete LC procedure because of severe
pericholecystic inflammation.
Percutaneous transhepatic gallbladder drainage (PTGD)
is a minimally invasive image-guided procedure designed
to decompress the acutely inflamed gallbladder by
draining the bile or pus from the bile duct using percu-
taneous liver gallbladder puncture catheter [11, 12].
PTGD is a palliative therapy recommended as an first-
lone therapeutic choice in the elderly and high risk AC
patients, and is performed as a simple operation, with
low requirement for sophisticated equipment, lesser
trauma and pain to the patients, and high efficiency
and quick recovery [13–16]. The most frequent im-
aging guide tool for PTGD is ultrasound, which pro-
vides images in real-time without the risks of radiation,
and is highly economical [17]. A few previous studies
observed that when LC is preceded by PTGD, there
were minimal rates of conversion and low perioperative
morbidity and mortality in high-risk AC patients
[18–20]. Based on the previous studies, we hypothe-
sized that elderly and high-risk AC patients may derive
significant clinical benefit from PTGD under the
guidance of B-mode ultrasound and followed by LC
[21–23]. In this study, we test our hypothesis by inves-
tigating the clinical value of sequentially combining
PTGD under the guidance of B-ultrasound with LC as
a minimally invasive treatment procedure in elderly
and high-risk AC patients.
Methods
Ethics statement
The study was approved by the Institutional Review
Board of the First People’s Hospital of Wenzhou, China.
The informed written consent was collected from each
eligible patient and the whole study was performed
based on the guidelines and principles of the Declaration
of Helsinki [24].
Study subjects
This study enrolled 35 elderly (all > 65 years old) and
high-risk AC patients who underwent B-mode ultrasound-
guided PTGD combined with LC (PTGD + LC group)
at Ethe First People’s Hospital of Wenzhou between
January 2010 and April 2014. A separate group of 35
elderly and high-risk AC patients were randomly se-
lected from a pool of 186 cases who underwent only
LC (LC group) during the same period at the same hos-
pital. The PTGD + LC group contained 23 males and
12 females, with a mean age of 69.2 ± 11.4 years. The
LC group contained 20 males and 15 females, with a
mean age of 71.5 ± 11.5 years. The diagnostic criteria
and evaluation of severity were based on the revised
Tokyo guidelines 2012, namely, local signs of inflamma-
tion (Murphy’s sign and right upper quadrant mass/
pain/tenderness), systemic symptoms of inflammation
(fever, elevated white blood cell count and elevated
C-reactive protein), and findings from computed tom-
ography (CT) scans and ultrasonograms [25, 26]. By ad-
mission time, the onset period in patients ranged from
6 h to 72 h, with an average of 30 h. All the patients
had upper abdominal pain or right upper abdominal
pain. Among the total 70 patients in this study, 46 cases
had fever, 54 cases had shoulder and back radiating
pain and all patients exhibited right upper abdominal
tenderness by physical examination. A total of 51 cases
showed positive Murphy’s sign and 40 cases had palp-
able and swollen gallbladder with tenderness. Leuko-
cytes count in all patients were elevated and were in
the 2.2 ± 0.5 grade, based on the American Society of
Anesthesiologists (ASA) grade. Gallbladder swelling
and wall thickening were found using liver and gall-
bladder B-ultrasound and 26 cases had pericholecystic
fluid and 63 cases had cholecystolithiasis. All subjects
in the LC and PTGD + LC groups met the following
study inclusion and exclusion criteria. Inclusion criteria:
(1) elderly AC patients (>65 years old) with cardiac, brain
and lung comorbidities, and unable to tolerate surgery;
(2) patients with AC and empyema of gall-bladder, fail-
ing to response well to non-surgical therapies; (3) se-
vere AC patients with disease for more than 48–72 h,
diameter of gallbladder enlargement 8 cm, and gallblad-
der wall of thickening 4 mm. Exclusion criteria: (1) pa-
tients with dysfunction in blood coagulation and severe
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bleeding tendency; (2) patients with massive ascites; (3)
patients with gallbladder in free state; (4) patients’ gall-
bladder with clear or inappropriate puncture route; (5) pa-
tients with general peritonitis and suspected perforation
of gallbladder.
PTGD treatment
All patients received routine blood, urine and feces examin-
ation and biochemical tests. Patients were given routine
fluid replacement to balance fluids, electrolytes, and to
maintain acid–base equilibrium and nutrition. Treatments
for infections were given if routine blood examination sup-
ported such intervention and the patients with hemorrhagic
shock were managed by quickly controlling the source of
bleeding and resuscitation [27]. PTGD+ LC in elderly high-
risk AC patients was accomplished by PTGD guided by B-
Ultrasound. Patients were primarily scanned by B-
Ultrasound in right lateral decubitus or supine position and
the puncture plan was simulated based on the image, with
corresponding marks on the patient. After local disinfection
and draping, 5 % lidocaine (5 ml) local anesthesia was ad-
ministered and an incision of 2 ~ 3 mm was made. Using
B-Ultrasound guidance, an 18-gauge puncture needle
(Angiotech Company, Denmark) was advanced transhepati-
cally into the gallbladder. After placing a guide wire and di-
lating the track, a 6Fr ~ 10Fr pigtail catheter was positioned
with its tip in the gallbladder, followed by pull out the guide
wire and placing the drainage bag. After PTGD surgery, the
drainage tube was washed with metronidazole injection
twice a day and patients were observed for pneumothorax,
bile peritonitis and other complications. In AC patients
with cardiovascular and cerebrovascular diseases [28], the
systolic blood pressure (SBP) in hypertensive patients was
controlled under 140mmHG. In AC patients with diabetes
mellitus [29], fasting glucose was controlled within 4.5 ~
8.0 mmol/L. In patients with cardiac insufficiency [30], the
heart function grade was kept under grade 2. In patients
with asthma [31], chronic bronchitis [32] and other respira-
tory diseases, the infection status was monitored and ap-
propriately controlled, and anti-inflammatory and phlegm
elimination was employed, with maximal ventilatory vol-
ume over 60 ~ 70 %.
PTGD postoperative index
The patient’s condition after PTGD was evaluated: (1)
symptoms: abdominal pain grade, body temperature; (2)
body signs: abdominal tenderness; (3) laboratory exam-
ination: leukocyte counts, alkaline phosphatase (ALP),
alanine transaminase (ALT), aspartate aminotransferase
(AST), total bilirubin (TB) and carbohydrate antigen 19-
9 (CA19-9); reexamination of liver and gallbladder by
the B-ultrasound after surgery for two weeks to detect
the gallbladder wall thickness and pericholecystic fluid
situation. Visual analogue scale (VAS) was adopted for
pain grading. After achieving symptomatic relief, pa-
tients in PTGD + LC group were given LC within 6 ~
10 weeks (average of 8 weeks) after PTGD.
LC treatment
A cannula (10 mm) was placed on the upper edge of umbil-
icus of the patients for inspection, in which 30° laparoscope
was set to observe the gallbladder and its surrounding area.
A 10 mm cannula was also placed below xiphoid bone
under direct vision and two cannula (5 mm) were placed in
right upper quadrant. Subsequently, the cystohepatic tri-
angle of patients, with head up in left lateral position, was
separated. The gallbladder was stripped off the liver with
electrocautery. Patients were intramuscularly injected with
Hemocoagulase 1U (Zhaoke Pharmaceutical (Hefei) Co.,
Ltd., China) for 2 days, each day for 8 h. Hemocoagulase is
a proteolytic enzyme used as a plasma clotting agent for fi-
brinogen and for detection of fibrinogen degradation prod-
ucts. It is a hemostatic drug used to treat primary and
secondary bleeding in postoperative period. Patients were
also treated immediately if their blood glucose and blood
pressure changed significantly during transfusion.
LC postoperative evaluation index
All patients enrolled in this study were informed of the
benefits and risks of both interventions. All interventions
were provided by an experienced medical team with more
than 10 years of clinical and surgical experience. The team
included surgeon, an emergency physician and a gastro-
enterologist. After LC surgery, data was collected from the
patients in PTGD+LC group and LC group and the fol-
lowing parameters were compared: the duration of the sur-
gery, the amount of intraoperative bleeding, conversion rate
to laparotomy, postoperative complication rate, mortality,
length of stay. VAS was employed to grade pain.
Statistical analysis
Statistical analysis was performed using SPSS 17.0 soft-
ware (SPSS Inc., Chicago, IL, USA). Continuous data were
expressed as mean ± standard deviation (SD) and further
analyzed by t test. Categorical data in the study was tested




As shown in Table 1, the differences in age, gender, ASA
grade, abdominal pain grade, body temperature (°C), posi-
tive Murphy’s sign, leukocytes counts and B-ultrasound
gallbladder wall thickness showed no statistically signifi-
cant differences between the PTGD+ LC group and LC
group (all P > 0.05). All 35 patients in the PTGD+ LC
group had internal diseases (100 %) while 32 patients in
the LC group had internal diseases (91.4 %), and this
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difference in patients with internal diseases between the
two groups was not statistically significant (P = 0.077).
Postoperative situation
All 35 patients underwent PTGD successfully with an
average operation time of 50.4 (40 ~ 75) min. There were
24 cases (68.6 %) of positive bile bacteria cultures, in-
cluding E.coli and other bateria (Klebsiella pneumoniae,
Enterococcus faecium, Pseudomonas aeruginosa), and
antibacterial drugs were used for treatment for an aver-
age time of 4.3 ± 2.6d. As shown in Table 2, within 72 h
after PTGD surgery, patients’ body temperature was re-
stored to normalcy, and leukocyte counts, ALP , TB and
CA19-9 levels were also within the normal range, with
significant improvement compared to preoperative levels
(all P < 0.05). ALT and AST levels improved significantly
when compared with the preoperative levels (P < 0.05).
PTGD postoperative abdominal pain grading was lower
than the preoperative grading (2.3 ± 0.9 vs. 5.1 ± 1.5,
P < 0.001). The patients were reexamined 4 weeks after
PTGD surgery and thinner gallbladder wall (0.34 ± 0.20)
was noted by B-ultrasound of liver and gallbladder, and
ocal inflammation of gallbladder was significantly reduced.
There were 3 cases of postoperative complications after
PTGD surgery. Of the 3 cases, 2 cases had their ducts dis-
lodged and one case involved bleeding. All PTGD + LC
group patients underwent LC surgery within 6–10 weeks
(average of 8 weeks) after PTGD surgery.
Operative indexes
As shown in Table 3, the duration of LC surgery in PTGD
+ LC group was 55.6 ± 23.3 min, while it was 91.4 ±
25.1 min in the LC group. The length of hospital stay of
the PTGD+ LC group after LC surgery was 3.0 ± 1.3 d,
while it was 7.0 ± 1.7 d in the LC group. The differences of
operative duration and length of hospital stay was statisti-
cally significant between the two groups (P < 0.05 for
both). Intraoperative bleeding of the patients in PTGD+
LC group (28.7 ± 15.2 ml) was significantly lower than ob-
served in patients of the LC group (60.4 ± 16.4 ml), and
the differences were statistically significant (P < 0.001).
Three cases in PTGD+ LC group (8.6 %) and 10 cases in
LC group converted to laparotomy because of severe ad-
hesion of the gallbladder triangle or difficult exposure of
the gallbladder. The conversion rate to laparotomy rate of
the PTGD+ LC group was significantly lower than the LC
group (P = 0.031).
Postoperative complications
There were no deaths reported in the two groups. There
was 1 case of bile leakage and 1 case of wound infection
in the PTGD + LC group, showing a 5.7 % rate of post-
operative complications (2/35). There were 2 cases of
bile leakage, 2 cases of wound infection and 1 case each
of bleeding, hernia, pulmonary infarction and respiratory
failure in the LC group, showing a 22.9 % rate of postop-
erative complications (8/35). The postoperative compli-
cations rate of PTGD + LC group was significantly lower
than the LC group (χ2 = 4.20, P = 0.040).
Discussion
LC is a highly effective surgical procedure in AC pa-
tients. However, in elderly and high-risk patients with
Table 1 The baseline characteristics of the patients in PTGD +
LC group and LC group





Age 69.2 ± 11.4 71.5 ± 11.5 0.404
Gender (M/F) 23/12 20/15 0.461








ASA grade (average) 2.2 ± 0.6 2.2 ± 0.5 1.000
Abdominal pain grade 5.1 ± 1.5 4.9 ± 1.4 0.566
Body temperature (°C) 38.1 ± 0.8 37.8 ± 0.6 0.081
Positive Murphy’s sign 25 (71.4 %) 26 (74.3 %) 0.072
Leukocytes counts (per/ml) 12.3 ± 3.7 12.7 ± 3.5 0.644
Gallbladder wall thickness (cm) 0.68 ± 0.34 0.71 ± 0.28 0.688
M: male; F: female; PTGD: percutaneous transhepatic gallbladder drainage; LC:
laparoscopic cholecystectomy; CHD: coronary heart disease; COPD: chronic
obstructive pulmonary disease; CI: cerebral infarction; CRI: chronic renal
insufficiency; ASA grade: American Society of Anesthesiologists grade
Table 2 Clinical manifestations and alterations of laboratory
examination within 72 h after percutaneous transhepatic
gallbladder drainage surgery
Before PTGD After PTGD P
Abdominal pain grade 5.1 ± 1.5 2.3 ± 0.9 <0.001
Body temperature (°C) 38.1 ± 0.8 36.5 ± 1.5 <0.001
Leukocytes counts (×109/L) 12.3 ± 3.7 6.7 ± 3.5 <0.001
ALP (U/L) 144.3 ± 32.6 104.5 ± 16.7 <0.001
ALT (U/L) 74.9 ± 35.2 48.9 ± 24.0 <0.001
AST (U/L) 81.6 ± 41.2 39.6 ± 18.3 <0.001
TB (μmol/L) 42.3 ± 15.2 22.5 ± 11.4 <0.001
CA19-9 (U/mL) 620.5 ± 205.6 55.2 ± 20.1 <0.001
PTGD: percutaneous transhepatic gallbladder drainage; ALP: alkaline
phosphatase; ALT: alanine transaminase; AST: aspartate aminotransferase; TB:
total bilirubin; CA19-9: carbohydrate antigen 19-9
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other severe co-existing illnesses, higher mortality rates
and higher conversion rate to an open procedure is ob-
served during the acute phase [33, 34]. Therefore, elderly
and high-risk AC patients are in urgent need of improved
procedures and techniques to safely manage the disease,
which is important considering the rapidly growing elderly
populations worldwide [35]. Towards this goal, this study
investigated the efficacy and safety of B-mode ultrasound-
guided PTGD in combination with LC in elderly and
high-risk AC patients.
The main finding in our study is that B-ultrasound
guided PTGD, combined with LC, is superior to LC alone
for effective treatment of elderly and high-risk AC pa-
tients. AC is caused by an obstruction of cystic duct and
the drainage of gallbladder bile is an important compo-
nent in treatment of AC to relieve pain and reduce inflam-
mation [36]. The use of PTGD prior to LC has the
following benefits: first, PTGD is a simple, local and a
minimally invasive procedure used in patients with severe
systemic diseased, which makes them unsuitable for LC
[37]. Second, PTGD is excellent for decompression of
swollen gallbladder and prevents gallbladder necrosis and
perforation, achieving improved local circulation and con-
trol of infection. The congestive bile can be quickly be re-
leased from the body by puncturing and the clinical
symptoms of AC in patients are promptly relieved by this
procedure [38]. In our study, all 35 patients underwent
PTGD successfully. After the infected bile was drained,
the inflamed gallbladder was decompressed and the body
temperature in all 35 patients decreased to normal levels
within 72 h. All patients reported dramatically reduced ab-
dominal pain and their leukocyte counts were within nor-
mal range, with the levels of ALP, TB and CA19-9 also
decreased to normal range. Third, patients can receive
antibiotic therapy to relieve the symptoms of infection
such as fever and abdominal pain, after PTGD [39]. In our
study, we encountered 24 cases of positive bile bacteria
cultures, including E.coli and other bateria such as Klebsi-
ella pneumoniae, Enterococcus faecium, Pseudomonas
aeruginosa, and subsequently, antibacterial drugs were
used in these patients. Fourth, PTGD can be employed for
cholangiography, which is crucial for revealing the biliary
tract anatomy and for selection of therapy options. Pre-
operative cholangiography, using PTGD tube, can provide
a clear information on the bile duct, cystic duct and gall-
stone, and additionally intraoperative cholangiography can
greatly avoid injury [40]. Finally, PTGD allows the choice of
subsequent elective cholecystectomy, with minimal rates of
conversion, and is considered as a bridge in the elderly and
high-risk patient population, prior to LC [19]. In our study,
all 35 patients had LC surgery within 6–10 weeks after
PTGD surgery and these patients had lower conversion rate
to laparotomy and reduced postoperative complications
rates, compared with the patients who underwent LC alone.
B-mode is an accurate and non-invasive imaging modality
and is highly specific for detecting biliary obstruction and
gallstones. The segmental and subsegmental branches of
both the hepatic artery and the portal vein can be identified
and discriminated from bile ducts in B-mode [41]. Xu EJ
et al. also demonstrated that PTGD is more successful and
efficacious when guided by ultrasound imaging [17]. Both
Kim et al. and Shibasaki et al. demonstrated that PTGD is
a less invasive image-guided alternative designed to decom-
press the acutely inflamed gallbladder in patients who are
unresponsive to medical therapy or are at high risk for
cholecystectomy [18, 42].
Conclusion
In conclusion, our study provides strong evidence that
B-mode ultrasound-guided PTGD, combined with LC, is
superior to LC alone for treatment of AC in elderly and
high-risk patients. The advantages include minimal wound,
accelerated recovery, higher safety and efficacy, and fewer
complications. However, larger prospective randomized tri-
als are needed to confirm these findings.
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Table 3 Comparison of observation indexes of laparoscopic
cholecystectomy in patients between PTGD + LC group and LC





Operative duration (min) 55.6 ± 23.3 91.4 ± 25.1 <0.01
The amount of intraoperative
bleeding (ml)
28.7 ± 15.2 60.4 ± 16.4 <0.01
Conversion rate to
laparotomy (%)
3 (8.6 %) 10
(28.6 %)
0.031
Hospital length of stay (d) 3.0 ± 1.3 7.0 ± 1.7 <0.01
PTGD: percutaneous transhepatic gallbladder drainage, LC: laparoscopic cholecystectomy
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